News | Radiopharm Theranostics

ASX Releases

August 24, 2023

TerThera Terbium-161 isotope supply agreement expanded

Read more Read more

August 18, 2023

EGM Presentation

Read more Read more

August 18, 2023

EGM Results

Read more Read more

July 24, 2023

Dr Sherin Al-Safadi Appointed as Vice President Medical and Corporate Affairs

Read more Read more

June 13, 2023

Pivalate Educational Webinar 14 June 2023

Read more Read more

May 29, 2023

FDA Pre-IND Meeting Supports an IND Application for RAD101

Read more Read more

MEDIA releases

December 1, 2022

GenesisCare and RAD Partner to Bring World First Novel Radiopharmaceuticals to Australian Cancer Patients

Read more Read more

October 6, 2022

CEO Interview series with Wholesale Investor

Read more Read more

July 8, 2022

RAD to Start Prostate Cancer Trial, Interview with Financial News Network

Read more Read more

June 28, 2022

World Congress Trivehexin Poster Presentation Shows Encouraging Integrin Data

Read more Read more

May 18, 2022

CEO Riccardo Canevari Updates Investors and Discusses Licensing of a Asset from UCLA

Read more Read more

May 9, 2022

Radiopharm Theranostics panel discusses latest progress and understanding of the radiopharmaceutical sector

Read more Read more

Events and Presentations

July 31, 2023

Company Presentation July 2023

Read more Read more

Sign up to our mailing list.

Receive all the latest news from Radiopharm Theranostics.